Psychedelic Assisted Therapies & Research Certificate
Certification
Live
8,900
USD
Hybrid
8 Months
Awarded: Certificate of Completion
Description
The research and therapy training is conducted with learning processes embedded in self-reflection, community-building, embodied ways of knowing, and mentoring. Trainees learn a wide variety of necessary skills and knowledge bases, ranging from pharmacology of psychedelics to research design to psychedelic therapist competencies to the history of use of psychoactive plants across the globe to cultural competencies for working with diverse clients.
The program thoroughly covers clinical work with MDMA and psilocybin (the two medicines furthest along in the FDA drug development process) with additional coursework on ketamine-assisted psychotherapy (FDA-approved for specific clinical syndromes). In order to accomplish such a holistic enterprise, the program values and implements the deconstruction of various perspectives and cultural viewpoints, along with didactic and experiential learning with teachers representing diverse specializations. The global wisdom traditions related to alterations of consciousness (meditation, yoga, fasting, solo wilderness retreats, healing methods, etc.) play a role in the theoretical underpinnings of the curriculum, as well as being directly enacted as part of the personal/experiential aspect of the training.
Two core elements for our classes are diversity, inclusion, and belonging as well as navigating the challenges of non-profit and corporate influences in the field. We co-create a culture of belonging throughout the program for all trainees in order to foster safety, empathy, connection, and risk-taking. With special attention given to skill development as a psychedelic-assisted therapist, trainees will increase their cultural competencies and cultural humility, including the capacity for addressing microaggressions and implicit biases. Due to our robust commitment to an inclusive program environment, we conduct focus groups with under-represented recent graduates to assess progress regarding all aspects of diversity, equity, and inclusion in our program.
The program thoroughly covers clinical work with MDMA and psilocybin (the two medicines furthest along in the FDA drug development process) with additional coursework on ketamine-assisted psychotherapy (FDA-approved for specific clinical syndromes). In order to accomplish such a holistic enterprise, the program values and implements the deconstruction of various perspectives and cultural viewpoints, along with didactic and experiential learning with teachers representing diverse specializations. The global wisdom traditions related to alterations of consciousness (meditation, yoga, fasting, solo wilderness retreats, healing methods, etc.) play a role in the theoretical underpinnings of the curriculum, as well as being directly enacted as part of the personal/experiential aspect of the training.
Two core elements for our classes are diversity, inclusion, and belonging as well as navigating the challenges of non-profit and corporate influences in the field. We co-create a culture of belonging throughout the program for all trainees in order to foster safety, empathy, connection, and risk-taking. With special attention given to skill development as a psychedelic-assisted therapist, trainees will increase their cultural competencies and cultural humility, including the capacity for addressing microaggressions and implicit biases. Due to our robust commitment to an inclusive program environment, we conduct focus groups with under-represented recent graduates to assess progress regarding all aspects of diversity, equity, and inclusion in our program.
